CClinicalTrials.gg
CompletedNCT03322501Updated Jan 18, 2019

Pediatric Health Promotion Program

An interventional study of Provider Advice, Framed Messaging in Tobacco Use, sponsored by Georgetown University. Completed at 1 site in United States. Open to participants aged 13 Years to 17 Years. Per ClinicalTrials.gov, last updated 2019-01-18.

Sponsored by Georgetown University · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
350
Allocation
Not applicable
Ages
13 Years to 17 Years
Sex
All
01

Study summary

The purpose of the study is to determine if an Ask, Advise, Connect (AAC) intervention model benefits tobacco control outcomes for pediatric primary care providers (pPCP's) and their young patients.

02

Conditions studied

  • Tobacco Use
03

Who can participate

Ages eligible
13 Years to 17 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Well-child visit

Exclusion criteria

Exclusion Criteria:

-

04

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
350 participants (actual)

Study arms

  • Experimental
    Intervention

    The purpose of the study is to determine if an Ask, Advise, Connect (AAC) intervention model benefits tobacco control outcomes for pediatric primary care providers (pPCP's) and their young patients.

    Behavioral: Provider Advice, Framed Messaging

Interventions

  • BehavioralProvider Advice, Framed Messaging

    The purpose of the study is to determine if an Ask, Advise, Connect (AAC) intervention model benefits tobacco control outcomes for pediatric primary care providers (pPCP's) and their young patients.

05

What researchers measure

Primary outcomes

  1. Tobacco Use

    Time frame: 1 Month

06

Study locations

1 site
  • MedStar Georgetown University Hospital
    Washington, District of Columbia 20007, United States
07

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT03322501
Lead sponsor
Georgetown University
Responsible party
Sponsor
First posted
Oct 26, 2017
Start date
Aug 7, 2015
Primary completion
Nov 1, 2018
Completion
Nov 1, 2018
Last update
Jan 18, 2019

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion